CME ON-DEMAND
Registration: Free
Pacific AETC Nevada’s E-Learning
Online and On-Demand Learning
The Pacific AETC-NV offers engaging and interactive online learning opportunities to increase healthcare providers' knowledge and awareness of HIV and STI-related health topics. Online and on-demand programming offer an alternative to in-person sessions for busy healthcare professionals.
Pacific AETC Nevada’s E-Learning
The E-Learning Portal is a free, 508 compliant, HIV, Hepatitis, and STI online learning site offering CME, nursing CE, and pharmacy CE for Nevada’s healthcare professionals.
Registration - Free
There is no charge to participate in the sessions.
The Pacific AETC is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award $3,887,700.00. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.
Demystifying Latent Tuberculosis Infections and Treatment for the Primary Care Provider
Provides 0.75 hours of CE/CME credit.
Learning Objectives
Following participation in this course, participants should be able to:
-
Explain why identification and treatment of latent TB infection (LTBI) is key to eliminating TB disease
-
Explain the impact of LTBI on persons with HIV and the essential components of an individual TB Risk Assessment Tool
- Explain the advantages and disadvantages of TB blood tests, IGRAs.
- Describe other diagnostics necessary to distinguish LTBI from active TB disease given that TB skin tests (TST) or TB blood tests (IGRAs) cannot rule-out active tuberculosis disease.
-
Discuss the current recommended short-course treatments for LTBI and the advantages versus disadvantages, to inform appropriate use in clinical practice
Presenters
Janice Louie, MD, MPH is Medical Director of the San Francisco Department of Public Health Tuberculosis Prevention and Control Program, and Assistant Clinical Professor in the University of California San Francisco Department of Medicine. Her primary focus is to ensure continued excellence in the clinical management of tuberculosis, provide mentorship and training to fellows, residents, and other trainees, and advancing clinical practices in tuberculosis with a focus on the elderly.
Susan McElhany, DMD, is the Tuberculosis Program Manager for the Office of State Epidemiology, within the Nevada Division of Public and Behavioral Health, Department of Health and Human Services.
2021 Nevada Legislative Updates on HIV and STIs: Implications for YOUR Practice
Provides 0.75 hours of CE/CME credit.
Learning Objectives
Following participation in this course, participants should be able to:
- List legislative initiatives around HIV and STIs
- List requirements of SB211, SB275, and SB325
- Apply screening guidelines for STIs and HIV
- Understand HIV prevention (screening / PEP / PrEP) that can be implemented in various clinical settings
Presenter
Rosanne Sugay, M.D., MPH, AAHIVS, Physician, Wellness Center, University Medical Center of Southern Nevada, Medical Director, Pacific AETC- Nevada
Congenital Syphilis
Provides 1.00 hour of CE/CME credit.
Learning Objectives
Following participation in this course, participants should be able to:
- Describe congenital syphilis epidemiology
- Discuss screening updates and POT screening
- Explain the pathophysiology, manifestations, and treatment for congenital syphilis
Presenters
Rosalyn Plotzker, MD, MPH
Assistant Professor | UCSF Dept. of Epidemiology and Biostatistics | Clinical Faculty| California Prevention Training Center | Provider | UCSF Anal Neoplasia, Clinic, Research and Education (ANCRE) Center | Public Health Medical Officer| CDPH STD Control Branch
Elizabeth Kessler, MPH
OPHIE Surveillance Manager | Office of Public Health Investigations and Epidemiology | Division of Public and Behavioral Health | Nevada Department of Health and Human Services
Xylazine and HIV in the Era of Synthetic Street Drugs
Provides 1.00 hour of CE/CME credit.
Learning Objectives
Following participation in this course, participants should be able to:
- Describe how the sudden expansion of xylazine, fentanyl, and crystal methamphetamine use is related to the history of US drug markets since 1990
- Describe how each of these substances relate to one another in the experience of consumption and in their public health impact, including on HIV and drug overdose risk
- Examine avenues for novel public health interventions to minimize the risk of HIV, drug overdose, and related comorbidities, as well as to regulate drug markets to make them less toxic and less economically exploitative for both people who use drugs and people who sell them
Presenters
Fernando Montero, PhD
Chief T32 Postdoctoral Research Fellow
HIV Center for Clinical and Behavioral Studies
Department of Psychiatry
Columbia University
Online Registration for Xylazine and HIV in the Era of Synthetic Street Drugs